Treatment with P-gp modulators can provide more significant cytotoxicity by reducing effective concentrations by 100-fold (paclitaxel) or 351-fold (vinblastine) in MDR colorectal cancer SW620/Ad300 cells[31,32]. Here, PGP is linked to colorectal cancer.